Jazz Pharmaceuticals
JAZZ
#1764
Rank
โ‚น1.069 T
Marketcap
โ‚น17,367
Share price
1.48%
Change (1 day)
42.97%
Change (1 year)

Revenue for Jazz Pharmaceuticals (JAZZ)

Revenue in 2025 (TTM): โ‚น373.95 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น400.60 Billion. an increase over the revenue in the year 2024 that were of โ‚น349.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jazz Pharmaceuticals from 2005 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น383.09 B9.75%
2024 โ‚น349.06 B9.36%
2023 โ‚น319.19 B5.41%
2022 โ‚น302.81 B31.48%
2021 โ‚น230.30 B33.24%
2020 โ‚น172.85 B12.13%
2019 โ‚น154.15 B16.59%
2018 โ‚น132.21 B27.93%
2017 โ‚น103.35 B2.22%
2016 โ‚น101.11 B14.85%
2015 โ‚น88.03 B18.44%
2014 โ‚น74.33 B37.92%
2013 โ‚น53.89 B67.99%
2012 โ‚น32.08 B122.75%
2011 โ‚น14.40 B84.96%
2010 โ‚น7.78 B30.66%
2009 โ‚น5.96 B83.66%
2008 โ‚น3.24 B26.62%
2007 โ‚น2.56 B29%
2006 โ‚น1.98 B105.89%
2005 โ‚น0.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.320 T 1,228.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚น23.883 T 5,861.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
โ‚น188.82 B-52.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚น1.620 T 304.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel